Your session is about to expire
← Back to Search
Coping and Communication Skills Training for Gynecologic Cancers
Study Summary
This trial found that Journey Ahead was helpful in teaching communication and coping skills to women with gynecologic cancers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I was diagnosed with Stage 2 or higher cervical cancer or had a recurrence in the last 5 years.I can access the internet and participate in online sessions and telehealth chats.I am mostly active and can carry out my daily activities.I was diagnosed with ovarian, peritoneal, or fallopian tube cancer or had a recurrence in the last 5 years.I was diagnosed within the last 5 years and agree to participate.I've had cancer treatment or surgery within the last 5 years.I was diagnosed with advanced or recurrent endometrial cancer in the last 5 years.I have been diagnosed with uterine cancer or it has come back in the last 5 years.I am 18 years old or older.You can speak English.
- Group 1: Journey Ahead
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial taking on new participants?
"Per clinicaltrials.gov, this study is presently recruiting participants and was first advertised on July 14th 2020 with the latest update occuring on July 27th 2022."
What is the uppermost limit of participants involved in this research endeavor?
"Affirmative. Clinicaltrials.gov displays that this investigation, which was originally published on July 14th 2020, is currently seeking participants from one site and hopes to recruit 30 individuals in total."
What is the main purpose behind this research endeavor?
"This medical trial has been designed to measure shifts in depressive symptoms over a baseline period and two follow-up visits 6 months later. Secondary outcomes of interest include physical impairment, psychological flexibility, and positive emotional expression. Physical limitation is evaluated using the CARES questionnaire; acceptance & action with AAQ-II; while emotional expressiveness will be determined by the King & Emmons survey."
Share this study with friends
Copy Link
Messenger